These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2170136)

  • 41. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progress in understanding cytomegalovirus drug resistance.
    Emery VC
    J Clin Virol; 2001 Jun; 21(3):223-8. PubMed ID: 11397658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes.
    Smith IL; Cherrington JM; Jiles RE; Fuller MD; Freeman WR; Spector SA
    J Infect Dis; 1997 Jul; 176(1):69-77. PubMed ID: 9207351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemical pharmacology of acyclic nucleotide analogues.
    Bronson JJ; Ho HT; De Boeck H; Woods K; Ghazzouli I; Martin JC; Hitchcock MJ
    Ann N Y Acad Sci; 1990; 616():398-407. PubMed ID: 2078030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1998 Jan; 42(1):170-2. PubMed ID: 9449280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of antiviral immunotoxin and ganciclovir or cidofovir for the treatment of murine cytomegalovirus infections.
    Smee DF; Sidwell RW; Barnett BB
    Antiviral Res; 1996 Nov; 32(3):165-71. PubMed ID: 8955511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors.
    Tatarowicz WA; Lurain NS; Thompson KD
    J Infect Dis; 1992 Oct; 166(4):904-7. PubMed ID: 1326585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
    Bronson JJ; Ghazzouli I; Hitchcock MJ; Webb RR; Martin JC
    J Med Chem; 1989 Jul; 32(7):1457-63. PubMed ID: 2544723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rapid protein A binding radioimmunoassay for the evaluation of antiviral agents.
    Gangopadhyay NN; Whitley RJ; Chatterjee S
    J Virol Methods; 1994 Jul; 48(2-3):273-9. PubMed ID: 7527404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
    Cherrington JM; Fuller MD; Lamy PD; Miner R; Lalezari JP; Nuessle S; Drew WL
    J Infect Dis; 1998 Dec; 178(6):1821-5. PubMed ID: 9815243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
    Kiehl MG; Basara N
    Blood; 2001 Sep; 98(5):1626; author reply 1628. PubMed ID: 11547768
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
    Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
    Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance.
    Pérez JL
    Microbiologia; 1997 Sep; 13(3):343-52. PubMed ID: 9353754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.
    Sergerie Y; Boivin G
    J Clin Microbiol; 2003 Aug; 41(8):3897-900. PubMed ID: 12904413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.
    Neyts J; Sobis H; Snoeck R; Vandeputte M; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):269-79. PubMed ID: 8390357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo.
    Freitas VR; Fraser-Smith EB; Matthews TR
    Antiviral Res; 1989 Nov; 12(4):205-12. PubMed ID: 2559657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo.
    Bischofberger N; Hitchcock MJ; Chen MS; Barkhimer DB; Cundy KC; Kent KM; Lacy SA; Lee WA; Li ZH; Mendel DB
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2387-91. PubMed ID: 7840575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.
    Neyts J; De Clercq E
    Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.
    Banker AS; De Clercq E; Taskintuna I; Keefe KS; Bergeron-Lynn G; Freeman WR
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient.
    Knox KK; Drobyski WR; Carrigan DR
    Lancet; 1991 May; 337(8752):1292-3. PubMed ID: 1674092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.